Key Highlights

  • Fiscal 2026 Revenue moved up to USD 1.42 billion from USD 1.35 billion, while attributable Net Income crept to USD 257.7 million from USD 255.0 million.
  • Diluted per-share Earnings came in at USD 2.70, up from USD 2.62, and licensing sales rose 6% to USD 1.32 billion at a 92% gross margin.
  • A quarterly Dividend of USD 0.39 per share, declared November 17, 2026 and payable December 9, compares with USD 0.36 paid in each quarter of fiscal 2026.
  • Cash on hand declined from USD 701.9 million to USD 622.9 million, while Operating Cash Flow fell to USD 399.5 million from USD 472.2 million.

Licensing Growth Outpaces Product Revenue Erosion

Dolby Laboratories (NYSE:DLB) lodged its Annual Report for the year ended September 25, 2026, showing total revenue of USD 1,420.9 million against USD 1,349.1 million. Roughly 93% of revenue comes from licensing audio and imaging technology to about 1,000 device manufacturers. Licensing added USD 73.2 million, supported by imaging patents, Atmos adoption in automobiles and larger recoveries from licensees. Mobile contributed USD 281.7 million and PCs USD 145.9 million, with the PC figure weaker on softer unit shipments. Products and services sales dipped 1% to USD 99.7 million, and that segment's gross Margin fell to 16% from 24% as cloud customer support and cinema equipment maintenance costs grew, although licensing still earns a 92% gross margin.

Litigation and CEO Transition Push Overhead Higher

Dolby Laboratories (NYSE:DLB) saw general and administrative spending climb USD 15.1 million to USD 301.6 million. The filing ties USD 9.9 million of that rise to legal, professional and contractor work linked to litigation and Patent pool activity, plus USD 4.4 million of share-based compensation from award modifications tied to the CEO transition. Sales and Marketing outlays eased 3% to USD 350.0 million, while Research and Development held at USD 262.8 million. Other income declined to USD 33.4 million from USD 38.5 million, mainly due to lower equity-method income. The effective tax rate rose to 23% from 15%, producing a provision of USD 77.9 million that kept net income close to the prior year.

Dividend Step-Up Backed by Buybacks and Credit Lines

Dolby paid USD 136.3 million in dividends during fiscal 2026. The board's USD 0.39 rate sits about 8% above the USD 0.36 quarterly rate (calculated). Share repurchases reached USD 265.0 million, up from USD 125.0 million, and a fresh USD 350 million authorisation approved in July 2026 pushing total authorisations up to USD 3.65 billion. Working Capital stood at USD 911.4 million against USD 950.5 million a year earlier. Management believes cash and its revolving credit line can cover needs for at least the next twelve months. Dolby OptiView, a live streaming product, remains early, and the filing says it is uncertain whether it will become a material revenue source.

Where Things Stand

Dolby Laboratories (NYSE:DLB) lifted its dividend because cash generation stayed robust, even though earnings barely changed. Revenue rose about 5% (calculated), yet heavier litigation costs, CEO-transition Equity expense and a higher tax rate limited net income to a 1% gain. Cash generated from operations, USD 399.5 million, still exceeded the USD 136.3 million paid in dividends plus USD 265.0 million of buybacks. Track licensing recoveries, which flatter reported growth, the product margin and legal spending, along with the December 9 payment and the buyback pace under the new authorisation.